Pervasive Developmental Disorder
📧 Sign up to get email alerts when something new happens for Pervasive Developmental Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: Confirmatory Efficacy Trial of Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder [NA]
The clinical trial update indicates the confirmatory efficacy trial of Cognitive Enhancement Therapy for adults with Autism Spectrum Disorde…
-
CLINICAL_TRIALS trial_result · 2023-10-04Clinical Trial Update: An Open-Label Trial of Oxytocin in Adolescents With Autism Spectrum Disorders [NA]
Open-label trial evaluating oxytocin in adolescents with autism spectrum disorders; the study is completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-08-16Clinical Trial Update: A Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder [Phase 3]
A Phase 3 clinical trial evaluating oxytocin for social impairment in individuals with high-functioning autism spectrum disorder has complet…
-
CLINICAL_TRIALS trial_result · 2019-07-17Clinical Trial Update: Evaluation and Treatment of Copper/Zinc Imbalance in Children With Autism [Phase 1]
Phase 1 clinical trial investigating copper/zinc imbalance treatment in children with autism and pervasive developmental disorder; study ter…
-
CLINICAL_TRIALS trial_result · 2018-11-28Clinical Trial Update: Study of Aripiprazole in the Treatment of Pervasive Developmental Disorders [Phase 3]
Phase 3 clinical trial update for aripiprazole in treating pervasive developmental disorders has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-24Clinical Trial Update: Transcranial Magnetic Stimulation for Evaluation and Treatment of Repetetive Behaviors in Autism [Phase 2]
A Phase 2 clinical trial evaluating transcranial magnetic stimulation for evaluation and treatment of repetitive behaviors in autism was ter…
-
CLINICAL_TRIALS trial_result · 2017-01-13Clinical Trial Update: Placebo-Controlled Pilot Trial of Mecamylamine for Treatment of Autism Spectrum Disorders [Phase 1]
This document reports a completed placebo-controlled Phase 1 pilot trial of mecamylamine for autism spectrum disorders conducted by Ohio Sta…
-
CLINICAL_TRIALS trial_result · 2017-01-13Clinical Trial Update: Neurocircuitry of Autism- fMRI and Transcranial Magnetic Stimulation Studies [NA]
The trial evaluating neurocircuitry in autism with fMRI and transcranial magnetic stimulation was terminated, and results were posted in Jan…
-
CLINICAL_TRIALS trial_result · 2017-01-02Clinical Trial Update: An Open-Label Trial of Aripiprazole in Autism Spectrum Disorders [Phase 2]
An open-label Phase 2 study of aripiprazole in autism spectrum disorders has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone. [Phase 3]
A completed Phase 3 study assessing whether Risperidone causes any cognitive or motor effects in youths with several behavioral and developm…
-
CLINICAL_TRIALS trial_result · 2016-02-05Clinical Trial Update: Shared Decision Making to Improve Care and Outcomes for Children With Autism [NA]
This clinical trial update reports the completion of a study examining shared decision making to improve care and outcomes for children with…
-
CLINICAL_TRIALS trial_result · 2016-02-04Clinical Trial Update: Atomoxetine, Placebo and Parent Management Training in Autism [Phase 4]
Phase 4 study evaluating atomoxetine versus placebo in combination with parent management training for children with autism and related perv…
-
CLINICAL_TRIALS trial_result · 2014-06-04Clinical Trial Update: A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder. [Phase 2]
This update notes the completion of a Phase 2 trial of aripiprazole in children and adolescents with Asperger's Disorder and pervasive devel…
-
CLINICAL_TRIALS trial_result · 2006-05-03Clinical Trial Update: Trial of Low-Dose Naltrexone for Children With Pervasive Developmental Disorder (PDD) [Phase 1, Phase 2]
A clinical trial evaluating low-dose naltrexone in children with pervasive developmental disorder, spanning Phase 1 and Phase 2, with the tr…